 they are able to threaten the viability of independent pharmacies that serve a lot of rural and urban communities. The Pharmaceutical Care Management Association, the main industry group for PBMs, strongly disputed the FTC's report, pointing out anonymous sourcing and what the group referred to as cherry-picked case studies. Some current and former FTC officials concurred, along with some in academia.